CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [07/01/2025 07:28 PDT] CRMD Expected to Trade Down After Bearish Patterns Develop
• [06/11/2025 07:20 PDT] CRMD Expected to Trade Up After Bullish Patterns Develop
• [05/19/2025 16:12 PDT] CorMedix Inc. (NASDAQ:CRMD), Up By 100% ($11.04) From $11.04 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/13/2025 07:10 PDT] CRMD Expected to Trade Down After Bearish Patterns Develop